Related Experiment Video
Updated: Dec 31, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Characteristics and outcomes of critically ill patients with severe hyperammonemia
Katherine J Jacoby1, Parvati Singh2, Matthew E Prekker3
1Critical Care Medicine, Hennepin County Medical Center, Minneapolis, MN, United States of America.
Purpose:
To determine the etiology and outcomes of critically ill patients with severe hyperammonemia.
Materials And Methods:
Retrospective observational study of adults (18 years or older) admitted to a MICU from 2007 to 2016 who had a serum ammonia level >180 μmol/L (3 times the upper limit of normal).
Results:
The 78 patients (45 male, 32 female) had a median age of 52 (interquartile range [IQR] 46-58) years. Hyperammonemia occurred most often with acute-on-chronic liver failure (ACLF) (49 %) or decompensated cirrhosis (27 %) and less often as a consequence of prior gastric bypass (9%), acute hepatic failure (6%), or valproic acid (3%). Median serum ammonia level was 201 μmol/L (IQR 126-265, range 18-736) on admission, with peak value of 245 μmol/L (IQR 205-336, range 185-842). Fifty (64%) patients died during the hospitalization. Cerebral edema was documented in 8 (10%) patients, only one of whom survived. Six of the 8 patients with cerebral edema had hyperammonemia related to ACLF, giving an incidence of 14% in this subset of patients. Neither mortality nor cerebral edema was associated with peak ammonia level.
Conclusions:
Critically ill patients with severe hyperammonemia have a high mortality rate and are at risk of developing cerebral edema.
Related Concept Videos
Acute Respiratory Failure-III
Urea Cycle
Chronic Kidney Disease II: Clinical Manifestations
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

